These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. The acquired immunodeficiency syndrome and cryptococcosis. Karaffa CA; Rehm SJ; Keys TF Ann Intern Med; 1986 Jun; 104(6):891-2. PubMed ID: 3706942 [No Abstract] [Full Text] [Related]
46. Acquired immunodeficiency with disseminated cryptococcosis. Pippard MJ; Dalgleish A; Gibson P; Malkovsky M; Webster AD Arch Dis Child; 1986 Mar; 61(3):289-91. PubMed ID: 3963873 [TBL] [Abstract][Full Text] [Related]
47. Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Denning DW; Tucker RM; Hanson LH; Hamilton JR; Stevens DA Arch Intern Med; 1989 Oct; 149(10):2301-8. PubMed ID: 2552949 [TBL] [Abstract][Full Text] [Related]
48. [Current progress in antifungal therapy: the value of fluconazole]. Meunier F Rev Med Brux; 1990 Sep; 11(7):278-82. PubMed ID: 2218209 [TBL] [Abstract][Full Text] [Related]
49. [Cryptococcosis in AIDS: therapeutic concepts]. Ruf B Mycoses; 1990; 33 Suppl 1():55-64. PubMed ID: 2101865 [TBL] [Abstract][Full Text] [Related]
50. [Clinical description of three cases of cerebral cryptococcosis in patients with AIDS treated with fluconazole]. Izzo E; Piccinino R; Caruso I; Bisogno A; Pesce G; Liberti A Riv Eur Sci Med Farmacol; 1991; 13(3-4):173-7. PubMed ID: 1821053 [TBL] [Abstract][Full Text] [Related]
51. [Clinical significance of Cryptococcus neoformans in faeces of an AIDS patient]. Madueño A; Hernandez-Porto M; Alonso Socas MM; Lecuona M Rev Esp Quimioter; 2017 Apr; 30(2):140-141. PubMed ID: 28198172 [No Abstract] [Full Text] [Related]
52. In-vitro and in-vivo activities of SCH56592 against Cryptococcus neoformans. Hossain MA; Maesaki S; Mitsutake K; Kakeya H; Sasaki E; Tomono K; Tashiro T; Kohno S J Antimicrob Chemother; 1999 Dec; 44(6):827-9. PubMed ID: 10590286 [TBL] [Abstract][Full Text] [Related]
53. Recent advances in the treatment of systemic fungal infections. Walsh TJ Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615 [TBL] [Abstract][Full Text] [Related]
55. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole. Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221 [TBL] [Abstract][Full Text] [Related]
56. [Treatment of cryptococcosis in patients with acquired immunodeficiency syndrome]. Graybill JR Rev Clin Esp; 1995 Oct; 195 Suppl 3():26-30. PubMed ID: 9441302 [No Abstract] [Full Text] [Related]
57. Interaction between fluconazole and rifampicin. Coker RJ; Tomlinson DR; Parkin J; Harris JR; Pinching AJ BMJ; 1990 Oct; 301(6755):818. PubMed ID: 2224282 [No Abstract] [Full Text] [Related]
58. Management of cryptococcosis in non-HIV-related patients. Yao Z; Liao W; Chen R Med Mycol; 2005 May; 43(3):245-51. PubMed ID: 16010851 [TBL] [Abstract][Full Text] [Related]
59. Oral fluconazole in the treatment of pulmonary cryptococcosis in non-AIDS patients. Yew WW; Wong PC; Wong CF; Lee J; Chau CH Drugs Exp Clin Res; 1996; 22(1):25-8. PubMed ID: 8839634 [TBL] [Abstract][Full Text] [Related]
60. Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice. Polak A Chemotherapy; 1987; 33(5):381-95. PubMed ID: 2822362 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]